Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.00%
#4 aPriori aPriori +152.64%
#5 Bedrock Bedrock +71.59%
#6 Cysic Cysic +51.82%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.96%
#9 Bitway Bitway +28.81%
#10 COTI COTI +27.28%
Coin of the day
Wrapped One Wrapped One
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Classificação em ações #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Preço da ação
$0.0009
Última sincronização: 2025-05-27
Valor de mercado
$1.15K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Arch Therapeutics, Inc. (ARTH)

Categoria

Healthcare
Receita da Arch Therapeutics, Inc. (ARTH)
Receita em Jun 2024 TTM: $148.16K
De acordo com os últimos relatórios financeiros da Arch Therapeutics, Inc., a receita atual da empresa (TTM) é $148.16K. Em 2022, a empresa obteve uma receita de $15.65K um aumento em relação a a receita do ano 2021, que foi de $11.57K. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Arch Therapeutics, Inc. de 2011 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $148.16K 95.66%
2023 $75.72K 383.80%
2022 $15.65K 35.34%
2021 $11.57K 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 8,520,448.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 4,063,861.52%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 6,823,996.90%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR